# accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis

Study · id `cardio:ct-nct03863132` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03863132](<https://clinicaltrials.gov/study/NCT03863132>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03863132

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.

## Technical summary

Registry record NCT03863132. Randomized; no masking; primary purpose treatment. Start 2019-07-03 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT03863132, source copy `cardio:ctgov-nct03863132-2026-11-09`, retrieved 2026-11-18)
- Started: 2019-07-03 (actual) (ClinicalTrials.gov record NCT03863132, source copy `cardio:ctgov-nct03863132-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT03863132, source copy `cardio:ctgov-nct03863132-2026-11-09`, retrieved 2026-11-18)
- Completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT03863132, source copy `cardio:ctgov-nct03863132-2026-11-09`, retrieved 2026-11-18)
- Countries: Germany; Italy; Switzerland (ClinicalTrials.gov record NCT03863132, source copy `cardio:ctgov-nct03863132-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03863132-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
- Acronym: REBOOT-PARADOX
- Condition: Aortic Valve Stenosis
- Intervention (Device): TAVR
- Lead sponsor: IHF GmbH - Institut für Herzinfarktforschung
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY
- Collaborator: Yale University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: IHF GmbH - Institut für Herzinfarktforschung (`cardio:org-ihf-gmbh-institut-fur-herzinfarktforschung`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)
- Registry lists this organization as a collaborator: Yale University (`cardio:org-yale-university`)

## Provenance

Content hash: 0cbca1976e9d548808ad5d06d9361781c7930d0b6b897c73ff6b697cfb0a7fdb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
